Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03347032 · ClinicalTrials.gov registry record · NA
Remote Ischemic Preconditioning for Renal Protection in TAVI
A NA study of Aortic Valve Stenosis and Renal Insufficiency, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT03347032 is a NA study of Aortic Valve Stenosis and Renal Insufficiency that has completed, run by Henry Ford Health System. The registered enrollment target is 46 participants, below the 1,042-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03347032, a NA study of Aortic Valve Stenosis and Renal Insufficiency, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
Severe aortic stenosis remains a major cause of morbidity and mortality of the elderly affecting approximately 3% of elderly patients with an increasing number of patients undergoing transcatheter aortic valve interventions. As part of pre-procedural planning these patients undergo CT scans and receive contrast during the procedure. These patients often have baseline renal insufficiency and are high risk of contrast induced nephropathy despite pre-hydration techniques. The purpose of this study is to evaluate the efficacy of this simple and safe procedure in preventing renal injury in this particular population.
Conditions Studied
Interventions
- PROCEDURE Control
- PROCEDURE Remote ischemic preconditioning
Study Locations (1)
Michigan
- Henry Ford Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2018-02-13 |
| Est. Completion | 2018-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03347032
The ClinicalTrials.gov registry entry for NCT03347032 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,042-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (96% lower). The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Aortic Valve Stenosis appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT03347032 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03347032 about?
NCT03347032 is a clinical study titled "Remote Ischemic Preconditioning for Renal Protection in TAVI". Severe aortic stenosis remains a major cause of morbidity and mortality of the elderly affecting approximately 3% of elderly patients with an increasing number of patients undergoing transcatheter aortic valve interventions. As part of pre-procedural planning these patients undergo CT scans and rece...
What is the current status of trial NCT03347032?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2018-02-13. Estimated completion is 2018-12-30.
What conditions does trial NCT03347032 study?
This clinical trial studies the following conditions: Aortic Valve Stenosis, Renal Insufficiency, Contrast Induced Nephropathy.
What interventions are being tested in trial NCT03347032?
The interventions under investigation include: Control (PROCEDURE), Remote ischemic preconditioning (PROCEDURE).
Who is sponsoring clinical trial NCT03347032?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03347032 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
MRI in Transcatheter Aortic Valve Replacement Patients
RECRUITING · NA
-
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
RECRUITING · NA
-
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
RECRUITING · NA
-
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
RECRUITING · NA
-
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.